{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:05:58Z","timestamp":1770980758655,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00204-013-1120-7","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T06:40:33Z","timestamp":1381128033000},"page":"455-473","source":"Crossref","is-referenced-by-count":52,"title":["The mixture of \u201cecstasy\u201d and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations"],"prefix":"10.1007","volume":"88","author":[{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Capela","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]},{"given":"V\u00e2nia","family":"Vilas-Boas","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa Maria","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Paula S\u00e9rio","family":"Branco","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"crossref","first-page":"e14097","DOI":"10.1371\/journal.pone.0014097","volume":"5","author":"M Adamaszek","year":"2010","unstructured":"Adamaszek M, Khaw AV, Buck U, Andresen B, Thomasius R (2010) Evidence of neurotoxicity of ecstasy: sustained effects on electroencephalographic activity in polydrug users. PLoS One 5:e14097","journal-title":"PLoS One"},{"key":"1120_CR2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1152\/ajpcell.00620.2006","volume":"292","author":"P Aguirre","year":"2007","unstructured":"Aguirre P, Vald\u00e9s P, Aracena-Parks P, Tapia V, N\u00fa\u00f1ez MT (2007) Upregulation of \u03b3-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells. Am J Physiol Cell Physiol 292:2197\u20132203","journal-title":"Am J Physiol Cell Physiol"},{"key":"1120_CR3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/tx990084t","volume":"12","author":"F Bai","year":"1999","unstructured":"Bai F, Lau SS, Monks TJ (1999) Glutathione and N-acetylcysteine conjugates of \u03b1-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem Res Toxicol 12:1150\u20131157","journal-title":"Chem Res Toxicol"},{"key":"1120_CR4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/tx010011l","volume":"14","author":"F Bai","year":"2001","unstructured":"Bai F, Jones DC, Lau SS, Monks TJ (2001) Serotonergic neurotoxicity of 3,4-(\u00b1)-methylenedioxyamphetamine and 3,4-(\u00b1)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of \u03b3-glutamyl transpeptidase. Chem Res Toxicol 14:863\u2013870","journal-title":"Chem Res Toxicol"},{"key":"1120_CR5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.2011.01453.x","volume":"165","author":"DJ Barbosa","year":"2012","unstructured":"Barbosa DJ, Capela JP, Oliveira JMA et al (2012) Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Br J Pharmacol 165:1017\u20131033","journal-title":"Br J Pharmacol"},{"key":"1120_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ceca.2012.03.004","volume":"52","author":"P Bernardi","year":"2012","unstructured":"Bernardi P, von Stockum S (2012) The permeability transition pore as a Ca2+ release channel: new answers to an old question. Cell Calcium 52:22\u201327","journal-title":"Cell Calcium"},{"key":"1120_CR7","first-page":"57","volume":"152","author":"JL Cadet","year":"2001","unstructured":"Cadet JL, Thiriet N, Jayanthi S (2001) Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne 152:57\u201359","journal-title":"Ann Med Interne"},{"key":"1120_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","volume":"316","author":"JP Capela","year":"2006","unstructured":"Capela JP, Meisel A, Abreu AR et al (2006a) Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316:53\u201361","journal-title":"J Pharmacol Exp Ther"},{"key":"1120_CR9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuroscience.2006.01.007","volume":"139","author":"JP Capela","year":"2006","unstructured":"Capela JP, Ruscher K, Lautenschlager M et al (2006b) Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139:1069\u20131081","journal-title":"Neuroscience"},{"key":"1120_CR10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neuro.2007.04.005","volume":"28","author":"JP Capela","year":"2007","unstructured":"Capela JP, Fernandes E, Remiao F, Bastos ML, Meisel A, Carvalho F (2007a) Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons. Neurotoxicology 28:868\u2013875","journal-title":"Neurotoxicology"},{"key":"1120_CR11","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.neuroscience.2007.03.028","volume":"146","author":"JP Capela","year":"2007","unstructured":"Capela JP, Macedo C, Branco PS et al (2007b) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146:1743\u20131757","journal-title":"Neuroscience"},{"key":"1120_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","volume":"39","author":"JP Capela","year":"2009","unstructured":"Capela JP, Carmo H, Remi\u00e3o F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210\u2013271","journal-title":"Mol Neurobiol"},{"key":"1120_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tox.2004.03.016","volume":"200","author":"M Carvalho","year":"2004","unstructured":"Carvalho M, Remiao F, Milhazes N et al (2004a) The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology 200:193\u2013203","journal-title":"Toxicology"},{"key":"1120_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/tx049960f","volume":"17","author":"M Carvalho","year":"2004","unstructured":"Carvalho M, Remi\u00e3o F, Milhazes N et al (2004b) Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem Res Toxicol 17:623\u2013632","journal-title":"Chem Res Toxicol"},{"key":"1120_CR15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","volume":"86","author":"M Carvalho","year":"2012","unstructured":"Carvalho M, Carmo H, Costa VM et al (2012) Toxicity of amphetamines: an update. Arch Toxicol 86:1167\u20131231","journal-title":"Arch Toxicol"},{"key":"1120_CR16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuro.2008.11.001","volume":"30","author":"Y Cheung","year":"2009","unstructured":"Cheung Y, Lau WK, Yu M et al (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30:127\u2013135","journal-title":"Neurotoxicology"},{"key":"1120_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0006-2952(95)02397-6","volume":"51","author":"T Chu","year":"1996","unstructured":"Chu T, Kumagai Y, DiStefano EW, Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51:789\u2013796","journal-title":"Biochem Pharmacol"},{"key":"1120_CR18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.bjp.0701213","volume":"121","author":"MI Colado","year":"1997","unstructured":"Colado MI, O\u2019Shea E, Granados R, Murray TK, Green AR (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (\u201cecstasy\u201d) and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889\u2013900","journal-title":"Br J Pharmacol"},{"key":"1120_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tips.2004.08.001","volume":"25","author":"R Torre de la","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M (2004) Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25:505\u2013508","journal-title":"Trends Pharmacol Sci"},{"key":"1120_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","volume":"49","author":"R Torre De La","year":"2000","unstructured":"De La Torre R, Farr\u00e9 M, Ortu\u00f1o J et al (2000) Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans. Br J Clin Pharmacol 49:104\u2013109","journal-title":"Br J Clin Pharmacol"},{"key":"1120_CR21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.128785","volume":"324","author":"GV Erives","year":"2008","unstructured":"Erives GV, Lau SS, Monks TJ (2008) Accumulation of neurotoxic thioether metabolites of 3,4-(\u00b1)-methylenedioxymethamphetamine in rat brain. J Pharmacol Exp Ther 324:284\u2013291","journal-title":"J Pharmacol Exp Ther"},{"key":"1120_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0706071","volume":"144","author":"I Escobedo","year":"2005","unstructured":"Escobedo I, O\u2019Shea E, Orio L et al (2005) A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol 144:231\u2013241","journal-title":"Br J Pharmacol"},{"key":"1120_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2010.11.001","volume":"58","author":"E Escubedo","year":"2011","unstructured":"Escubedo E, Abad S, Torres I, Camarasa J, Pubill D (2011) Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity. Neurochem Int 58:92\u2013101","journal-title":"Neurochem Int"},{"key":"1120_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130000645","volume":"154","author":"B Esteban","year":"2001","unstructured":"Esteban B, O\u2019Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251\u2013260","journal-title":"Psychopharmacology"},{"key":"1120_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/tx9003374","volume":"23","author":"A Felim","year":"2009","unstructured":"Felim A, Herrera G, Neud\u00f6rffer A, Blanco M, O\u2019Connor J, Largeron M (2009) Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(\u2212)-HHMA): comparison with related catecholamines. Chem Res Toxicol 23:211\u2013219","journal-title":"Chem Res Toxicol"},{"key":"1120_CR26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tips.2011.08.005","volume":"32","author":"CS Ferguson","year":"2011","unstructured":"Ferguson CS, Tyndale RF (2011) Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32:708\u2013714","journal-title":"Trends Pharmacol Sci"},{"key":"1120_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","volume":"216","author":"PS Ferreira","year":"2013","unstructured":"Ferreira PS, Nogueira TB, Costa VM et al (2013) Neurotoxicity of \u201cecstasy\u201d and its metabolites in human dopaminergic differentiated SH-SY5Y cells. Toxicol Lett 216:159\u2013170","journal-title":"Toxicol Lett"},{"key":"1120_CR28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.taap.2010.01.014","volume":"244","author":"S Garcia-Rat\u00e9s","year":"2010","unstructured":"Garcia-Rat\u00e9s S, Camarasa J, S\u00e1nchez-Garc\u00eda AI, Gand\u00eda L, Escubedo E, Pubill D (2010) The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: Intracellular calcium increase, calpain\/caspase 3 activation, and functional upregulation. Toxicol Appl Pharmacol 244:344\u2013353","journal-title":"Toxicol Appl Pharmacol"},{"key":"1120_CR29","first-page":"455","volume":"10","author":"R Gollamudi","year":"1989","unstructured":"Gollamudi R, Ali SF, Lipe G et al (1989) Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology 10:455\u2013466","journal-title":"Neurotoxicology"},{"key":"1120_CR30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.2008.05705.x","volume":"107","author":"N Granado","year":"2008","unstructured":"Granado N, O\u2019Shea E, Bove J, Vila M, Colado MI, Moratalla R (2008) Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 107:1102\u20131112","journal-title":"J Neurochem"},{"key":"1120_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","volume":"42","author":"N Granado","year":"2011","unstructured":"Granado N, Ares-Santos S, Oliva I et al (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391\u2013403","journal-title":"Neurobiol Dis"},{"key":"1120_CR32","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC et al (2011) NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One 6:e17963","journal-title":"PLoS One"},{"key":"1120_CR33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.110.171322","volume":"335","author":"BN Johnson","year":"2010","unstructured":"Johnson BN, Yamamoto BK (2010) Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. J Pharmacol Exp Ther 335:180\u2013189","journal-title":"J Pharmacol Exp Ther"},{"key":"1120_CR34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/jpet.104.077628","volume":"313","author":"DC Jones","year":"2005","unstructured":"Jones DC, Duvauchelle C, Ikegami A et al (2005) Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. J Pharmacol Exp Ther 313:422\u2013431","journal-title":"J Pharmacol Exp Ther"},{"key":"1120_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","volume":"1337","author":"FM Lopes","year":"2010","unstructured":"Lopes FM, Schr\u00f6der R, J\u00fanior MLC et al (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85\u201394","journal-title":"Brain Res"},{"key":"1120_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"1120_CR37","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","volume":"18","author":"JE Malberg","year":"1998","unstructured":"Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086\u20135094","journal-title":"J Neurosci"},{"key":"1120_CR38","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1016\/j.bbagen.2012.10.018","volume":"1830","author":"M Mar\u00ed","year":"2013","unstructured":"Mar\u00ed M, Morales A, Colell A, Garc\u00eda-Ruiz C, Kaplowitz N, Fern\u00e1ndez-Checa JC (2013) Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta 1830:3317\u20133328","journal-title":"Biochim Biophys Acta"},{"key":"1120_CR39","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/tx060123i","volume":"19","author":"N Milhazes","year":"2006","unstructured":"Milhazes N, Cunha-Oliveira T, Martins P et al (2006) Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) and its metabolites on undifferentiated PC12 cells: a putative structure\u2013toxicity relationship. Chem Res Toxicol 19:1294\u20131304","journal-title":"Chem Res Toxicol"},{"key":"1120_CR40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","volume":"106","author":"KM Morefield","year":"2011","unstructured":"Morefield KM, Keane M, Felgate P, White JM, Irvine RJ (2011) Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users. Addiction 106:1293\u20131300","journal-title":"Addiction"},{"key":"1120_CR41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/FTD.0b013e3181a4f6c2","volume":"31","author":"M Mueller","year":"2009","unstructured":"Mueller M, Kolbrich EA, Peters FT et al (2009a) Direct comparison of (\u00b1) 3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) disposition and metabolism in squirrel monkeys and humans. Ther Drug Monit 31:367\u2013373","journal-title":"Ther Drug Monit"},{"key":"1120_CR42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1124\/dmd.109.028340","volume":"37","author":"M Mueller","year":"2009","unstructured":"Mueller M, Yuan J, Felim A et al (2009b) Further studies on the role of metabolites in (\u00b1)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity. Drug Metab Dispos 37:2079\u20132086","journal-title":"Drug Metab Dispos"},{"key":"1120_CR43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0006-8993(01)03229-2","volume":"924","author":"HN Nguyen","year":"2002","unstructured":"Nguyen HN, Wang C, Perry DC (2002) Depletion of intracellular calcium stores is toxic to SH-SY5Y neuronal cells. Brain Res 924:159\u2013166","journal-title":"Brain Res"},{"key":"1120_CR44","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1074\/jbc.M807459200","volume":"284","author":"JMA Oliveira","year":"2009","unstructured":"Oliveira JMA, Gon\u00e7alves J (2009) In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum. J Biol Chem 284:5010\u20135020","journal-title":"J Biol Chem"},{"key":"1120_CR45","doi-asserted-by":"crossref","first-page":"251258","DOI":"10.1016\/0169-328X(89)90059-4","volume":"5","author":"KR Pennypacker","year":"1989","unstructured":"Pennypacker KR, Kuhn DM, Billingsley ML (1989) Changes in expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation. Brain Res Mol Brain Res 5:251258","journal-title":"Brain Res Mol Brain Res"},{"key":"1120_CR46","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1523\/JNEUROSCI.1042-10.2010","volume":"30","author":"SW Perry","year":"2010","unstructured":"Perry SW, Barbieri J, Tong N et al (2010) Human immunodeficiency virus-1 tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J Neurosci 30:14153\u201314164","journal-title":"J Neurosci"},{"key":"1120_CR47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0090-9556(24)02984-2","volume":"32","author":"N Pizarro","year":"2004","unstructured":"Pizarro N, Farre M, Pujadas M et al (2004) Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine). Drug Metab Dispos 32:1001\u20131007","journal-title":"Drug Metab Dispos"},{"key":"1120_CR48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","volume":"5","author":"S Presgraves","year":"2003","unstructured":"Presgraves S, Ahmed T, Borwege S, Joyce J (2003) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579\u2013598","journal-title":"Neurotox Res"},{"key":"1120_CR49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2009.07.040","volume":"1292","author":"GMP Roberts","year":"2009","unstructured":"Roberts GMP, Nestor L, Garavan H (2009) Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task. Brain Res 1292:71\u201381","journal-title":"Brain Res"},{"key":"1120_CR50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tins.2006.11.004","volume":"30","author":"T Satoh","year":"2007","unstructured":"Satoh T, Lipton SA (2007) Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 30:37\u201345","journal-title":"Trends Neurosci"},{"key":"1120_CR51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(86)90140-8","volume":"124","author":"CJ Schmidt","year":"1986","unstructured":"Schmidt CJ, Wu L, Lovenberg W (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Eur J Pharmacol 124:175\u2013178","journal-title":"Eur J Pharmacol"},{"key":"1120_CR52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/toxsci\/kfm302","volume":"102","author":"S Shavali","year":"2008","unstructured":"Shavali S, Sens DA (2008) Synergistic neurotoxic effects of arsenic and dopamine in human dopaminergic neuroblastoma SH-SY5Y cells. Toxicol Sci 102:254\u2013261","journal-title":"Toxicol Sci"},{"key":"1120_CR53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","volume":"69","author":"D Sulzer","year":"2011","unstructured":"Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69:628\u2013649","journal-title":"Neuron"},{"key":"1120_CR54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejphar.2011.03.046","volume":"660","author":"F Sun","year":"2011","unstructured":"Sun F, Zhang L, Zhang R, Li L (2011) Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Eur J Pharmacol 660:283\u2013290","journal-title":"Eur J Pharmacol"},{"key":"1120_CR55","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.21869","volume":"87","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi H, Yanagida T, Inden M et al (2009) Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson\u2019s disease models. J Neurosci Res 87:576\u2013585","journal-title":"J Neurosci Res"},{"key":"1120_CR56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tiv.2005.01.006","volume":"19","author":"MA Tirmenstein","year":"2005","unstructured":"Tirmenstein MA, Hu CX, Scicchitano MS et al (2005) Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol In Vitro 19:471\u2013479","journal-title":"Toxicol In Vitro"},{"key":"1120_CR57","doi-asserted-by":"crossref","first-page":"e9143","DOI":"10.1371\/journal.pone.0009143","volume":"5","author":"C Touri\u00f1o","year":"2010","unstructured":"Touri\u00f1o C, Zimmer A, Valverde O (2010) THC prevents MDMA neurotoxicity in mice. PLoS One 5:e9143","journal-title":"PLoS One"},{"key":"1120_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2004.11.041","volume":"376","author":"X Wang","year":"2005","unstructured":"Wang X, Xu J (2005) Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 376:127\u2013132","journal-title":"Neurosci Lett"},{"key":"1120_CR59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S1461145706007061","volume":"10","author":"MW Warren","year":"2007","unstructured":"Warren MW, Zheng W, Kobeissy FH et al (2007) Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. Int J Neuropsychopharmacol 10:479\u2013489","journal-title":"Int J Neuropsychopharmacol"},{"key":"1120_CR60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12031-012-9926-y","volume":"49","author":"B Xu","year":"2013","unstructured":"Xu B, Xu Z, Deng Y, Liu W, Yang H, Wei Y (2013) MK-801 protects against intracellular Ca2+ overloading and improves N-methyl-d-aspartate receptor expression in cerebral cortex of methylmercury-poisoned rats. J Mol Neurosci 49:162\u2013171","journal-title":"J Mol Neurosci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1120-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-013-1120-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1120-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T15:48:01Z","timestamp":1746028081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-013-1120-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1007\/s00204-013-1120-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}